Delivery Order SPE2DB24D1021-SPE2DB25FEZEF
- Not listed
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a $4,531.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with an ultimate completion date of August 5, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, valued at $1,403.88. This firm fixed price delivery order, which is not set-aside and was competitively awarded, is set for ultimate completion on July 29, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order valued at $6,117.34 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a quantity of 90s. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The products will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This contract, valued at $1,802.80 with a firm fixed price structure, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by July 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,081.68, for the supply of Letrozole 2.5 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 6, 2025. The award was issued on August 5, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Letrozole is a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,672.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,110,874 Letrozole 2.5 mg tablets. The order has an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Letrozole 2.5 mg tablets. The $1,075.22 contract has a completion date of February 14, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor for this order, which is issued under a larger indefinite delivery contract with DLA Troop Support Medical, valued at up to...
- This is a $1,705.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count packages of the medication Letrozole 2.5 mg tablets. The contract is not set aside, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZEFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (30-count) under a firm fixed-price contract valued at $6,868.86. The order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's extensive IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this vehicle, the company serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to meet varied and substantial federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/1/25 |